Optoacoustic imaging (OAI) offers a unique method to study skin at depths and resolution beyond traditional optical techniques. The capacity to image morphological, vascular and biochemical changes in the skin could expand the understanding of pathophysiology and therapy response in a range of skin diseases including cancer and inflammation. In this webinar, Dr. Dinish U S, Group Leader, and Dr. Chris Ho, Business Development Manager, at the Singapore Bioimaging Consortium (SBIC) present their work using Multispectral Optoacoustic Tomography (MSOT) and Raster-Scanning Optoacoustic Mesoscopy (RSOM).
